1. Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226). (3rd April 2023) Authors: Bergqvist, Mattias; Nordmark, Adrian; Williams, Amy; Paoletti, Costanza; Barlow, William; Cobain, Erin F.; Mehta, Rita S.; Gralow, Julie R.; Hortobagyi, Gabriel N.; Albain, Kathy S.; Pusztai, Lajos; Sharma, Priyanka; Godwin, Andrew K.; Thompson, Alastair M.; Hayes, Daniel F.; Rae, James M. Journal: Biomarkers Issue: Volume 28:Number 3(2023) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗